About Mid-America Retina Consultants, P.A.
Clinical Trials at Mid-America Retina Consultants, P.A.
During the past decade, Mid-America Retina Consultants, P.A. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mid-America Retina Consultants, P.A."
#1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Mid-America Retina Consultants, P.A.
According to Clinical.Site data, the most researched conditions in "Mid-America Retina Consultants, P.A." are
"Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (2 trials), "Full-thickness Macular Holes (MH)" (1 trials), "Proliferative Diabetic Retinopathy" (1 trials) and "Vitreomacular Traction" (1 trials). Many other conditions were trialed in "Mid-America Retina Consultants, P.A." in a lesser frequency.
Clinical Trials Intervention Types at Mid-America Retina Consultants, P.A.
Most popular intervention types in "Mid-America Retina Consultants, P.A." are "Drug" (5 trials), "Procedure" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Prompt aflibercept" (2 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials) and "Bevacizumab + Deferred Aflibercept Group" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mid-America Retina Consultants, P.A.
The vast majority of trials in "Mid-America Retina Consultants, P.A." are
7 trials for "All" genders.
Clinical Trials Status at Mid-America Retina Consultants, P.A.
Currently, there are NaN active trials in "Mid-America Retina Consultants, P.A.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Mid-America Retina Consultants, P.A.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mid-America Retina Consultants, P.A., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".